[EN] N-HETARYL-SQUARAMIDE COMPOUNDS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY<br/>[FR] COMPOSÉS N-HÉTARYL-SQUARAMIDE POUR LE TRAITEMENT D'AFFECTIONS ASSOCIÉES À UNE ACTIVITÉ DE STING
申请人:IFM DUE INC
公开号:WO2020236586A1
公开(公告)日:2020-11-26
This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt, and/or hydrate, and/or cocrystal, and/or drug combination of the compound) that inhibit (e.g., antagonize) Stimulator of Interferon Genes (STING). Said chemical entities are useful, e.g., for treating a condition, disease or disorder in which increased (e.g., excessive) STING activation (e.g., STING signaling) contributes to the pathology and/or symptoms and/or progression of the condition, disease or disorder (e.g., cancer) in a subject (e.g., a human). This disclosure also features compositions containing the same as well as methods of using and making the same.
本公开涉及化学实体(例如,化合物或药物可接受的盐、水合物、共晶体和/或化合物的药物组合),用于抑制(例如,对抗)干扰素基因刺激器(STING)。所述化学实体可用于治疗在受体(例如,人类)中,增强(例如,过度)STING激活(例如,STING信号传导)导致病理学和/或症状和/或疾病或障碍(例如,癌症)的进展的情况、疾病或障碍。本公开还涉及包含相同的组合物以及使用和制造相同的方法。